| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |